| AABFX | BIICX | AABFX / BIICX | |
| Total Expense Ratio | 0.99 | 0.57 | 174% |
| Annual Report Gross Expense Ratio | 1.03 | 0.68 | 151% |
| Fund Existence | 28 years | 18 years | - |
| Gain YTD | 11.626 | 10.749 | 108% |
| Front Load | 5% | N/A | - |
| Min. Initial Investment | 2000 | 2000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 444M | 10.6B | 4% |
| Annual Yield % from dividends | 2.65 | 5.74 | 46% |
| Returns for 1 year | 8.52 | 9.90 | 86% |
| Returns for 3 years | 31.96 | 33.12 | 96% |
| Returns for 5 years | 26.27 | 27.55 | 95% |
| Returns for 10 years | 48.09 | 66.94 | 72% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| KNGZ | 35.49 | 0.27 | +0.76% |
| FirstTrust S&P500 DvrsDiv AristocratsETF | |||
| BMEZ | 15.05 | 0.06 | +0.40% |
| BlackRock Health Sciences Term Trust | |||
| THNR | 24.46 | N/A | N/A |
| Amplify Weight Loss Drug & Treatment ETF | |||
| TJAN | 27.11 | N/A | -0.01% |
| Innovator Equity Defined Protection ETF - 2 Yr to January 2027 | |||
| HYGW | 30.07 | -0.03 | -0.10% |
| iShares High Yld Crp Bd Buywrt Stgy ETF | |||